
The zzso zzso zzso of zzso zzso oxide zzso was used to treat human zzso zzso zzso zzso zzso 2 h zzso A collection of zzso zzso zzso was isolated and characterized by zzso sequencing of cloned zzso zzso zzso substitution zzso in the zzso coding region were observed in zzso of zzso zzso 11 occurred at AT base pairs and 8 at zzso base zzso Two zzso zzso zzso involving zzso bases were also zzso zzso half zzso of the zzso zzso displayed the complete loss of single and multiple zzso from zzso zzso as well as small zzso some extending from zzso zzso Southern zzso analysis of 5 zzso with single zzso losses revealed no visible zzso Analysis of 1 zzso missing zzso 3-6 in its zzso zzso revealed a visible deletion in the corresponding region in its zzso zzso The missing zzso regions of 4 zzso (one each with zzso 6, 7 and 8 loss and one zzso with a zzso deletion of the zzso region of zzso 9) were zzso amplified from zzso DNA and analyzed by Southern zzso using zzso zzso The zzso missing from the zzso zzso were present in the zzso zzso zzso DNA sequencing of the appropriate zzso regions of zzso zzso DNA from a zzso with zzso 8 loss and a zzso exhibiting zzso zzso in zzso 9 revealed point zzso in the zzso zzso site of zzso 8 zzso and zzso 9 zzso zzso 

